» Articles » PMID: 2448658

Forskolin Blocks Carbachol-mediated Ion-permeability of Chick Myotube Nicotinic Receptors and Inhibits Binding of 3H-phencyclidine to Torpedo Microsac Nicotinic Receptors

Overview
Specialty Pharmacology
Date 1987 Oct 1
PMID 2448658
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Forskolin, a commonly used adenylate cyclase activator, was found to inhibit reversibly the carbachol-induced ion-translocating capacity of the nicotinic acetylcholine receptor (nAChR) on chick myotubes in a dose- (IC50 = 20 microM) and time-dependent manner. This effect was not correlated to increases in cellular cAMP. Forskolin, at a concentration (50 microM) that totally blocked the carbachol-induced 86Rb influx, caused no change in carbachol or alpha-bungarotoxin binding to chick myotube nAChR in situ. In contrast, in the presence of carbachol, forskolin inhibited (IC50 = 10 microM) the binding of 3H-phencyclidine, a putative nAChR ion-channel ligand, to Torpedo microsac nAChR. Inhibition of 3H-phencyclidine binding in the absence of carbachol was not complete. Membrane leakage studies on myotubes, measuring 3H-efflux from 2-deoxy-D(1-3H)-glucose loaded cells and electrophysiological measurements of membrane properties supported the interpretation that forskolin induced decreases in plasma membrane permeability. In conclusion, forskolin blocks the carbachol-mediated increase in permeability of the nAChR channel by (1) binding to the ion-channel (open state) and (2) generally perturbing the plasma membrane function possibly by interfering with the protein-lipid interface.

Citing Articles

Desensitization of the acetylcholine receptor of frog end-plates measured in a Vaseline-gap voltage clamp.

Cachelin A, Colquhoun D J Physiol. 1989; 415:159-88.

PMID: 2561785 PMC: 1189172. DOI: 10.1113/jphysiol.1989.sp017717.


Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.

Nishizawa Y, Seamon K, Daly J, Aronstam R Cell Mol Neurobiol. 1990; 10(3):351-68.

PMID: 1701359 PMC: 11567200. DOI: 10.1007/BF00711180.

References
1.
NASTUK W, Su P, Doubilet P . Anticholinergic and membrane activities of amantadine in neuromuscular transmission. Nature. 1976; 264(5581):76-9. DOI: 10.1038/264076a0. View

2.
Hedlund B, Arhem P, Lorentz M, Sydbom A . Non-muscarinic effects of scopolamine on N1E-115 neuroblastoma cells. Acta Physiol Scand. 1986; 127(1):127-32. DOI: 10.1111/j.1748-1716.1986.tb07884.x. View

3.
Heidmann T, Oswald R, Changeux J . Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983; 22(13):3112-27. DOI: 10.1021/bi00282a014. View

4.
Warnick J, Maleque M, Bakry N, Eldefrawi A, Albuquerque E . Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Mol Pharmacol. 1982; 22(1):82-93. View

5.
Albuquerque E, Deshpande S, Aracava Y, Alkondon M, Daly J . A possible involvement of cyclic AMP in the expression of desensitization of the nicotinic acetylcholine receptor. A study with forskolin and its analogs. FEBS Lett. 1986; 199(1):113-20. DOI: 10.1016/0014-5793(86)81235-2. View